Acadia Pharmaceuticals
ACAD
ACAD
212 hedge funds and large institutions have $4.44B invested in Acadia Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 67 increasing their positions, 72 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 72
1.9% less ownership
Funds ownership: 98.15% → 96.25% (-1.9%)
38% less call options, than puts
Call options by funds: $44.1M | Put options by funds: $71.4M
Holders
212
Holding in Top 10
4
Calls
$44.1M
Puts
$71.4M
Top Buyers
| 1 | +$86.5M | |
| 2 | +$30.1M | |
| 3 | +$19.5M | |
| 4 |
TA
Teachers Advisors
New York
|
+$15.1M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$14.5M |
Top Sellers
| 1 | -$51.7M | |
| 2 | -$25.6M | |
| 3 | -$21M | |
| 4 |
Millennium Management
New York
|
-$19.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$19.1M |